Verwandte Artikel zu An Overview of FDA Regulated Products: From Drugs and...

An Overview of FDA Regulated Products: From Drugs and Cosmetics to Food and Tobacco - Softcover

 
9780443237805: An Overview of FDA Regulated Products: From Drugs and Cosmetics to Food and Tobacco
Softcover
ISBN 10: 0443237808 ISBN 13: 9780443237805
Verlag: Academic Press, 2025

Inhaltsangabe

An Overview of FDA Regulated Products: From Drugs and Cosmetics to Food and Tobacco, Second Edition is fully updated to reflect recent advances in science and technology and new laws and regulations. Breakthroughs in cellular and gene therapy, immunotherapy, precision medicine, and digital health are changing the face of healthcare and regulation. The updates brought about by the 21st Century Cures Act and subsequent PDUFA Reauthorizations, as well as signing into law the “Modernization of Cosmetic Regulation Act of 2022,” which will transform FDA’s oversight of cosmetics, are fully reflected in all chapters of the book.

This book provides graduate students and industry professionals with comprehensive information on approval processes with the FDA and other country regulation organizations. Regulatory science professionals working with not only drugs, but biologics, medical devices, food and additives, cosmetics, veterinary products, and tobacco will benefit from this comprehensive overview of the regulatory environment.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Über die Autorinnen und Autoren

Eunjoo Pacifici received her doctor of pharmacy and PhD in toxicology from the University of Southern California. She conducted her graduate research in the laboratory of Dr. Alex Sevanian in the Institute for Toxicology at USC, where she studied the mechanism of oxidative damage and repair in endothelial cell membrane.

After receiving her graduate degrees, Pacifici worked at Amgen and gained experience in conducting clinical research with a special focus on Asia Pacific and Latin America regions. She initially worked in the clinical development group managing U.S. investigational sites and central laboratories and then went on to work in the Asia Pacific/Latin America group interfacing with local clinical and regulatory staff in Japan, People’s Republic of China, Taiwan and Mexico. She represented regional clinical and regulatory views on therapeutic product development teams and led satellite task forces in order to align local efforts with U.S. activities.

Susan Bain, DRSc, is an assistant professor of Regulatory and Quality Sciences at USC and previously was a professor of practice and program director for clinical, regulatory and quality at Keck Graduate Institute (KGI) and adjunct professor of practice and concentration coordinator for clinical and regulatory in KGI’s School of Pharmacy.

Dr. Bain is an accomplished quality and regulatory professional with experience in the medical device, pharmaceutical and biotechnology industries. She has a diverse regulatory compliance background in a broad range of FDA-regulated industries.

She received a doctorate of regulatory science, a master of science in regulatory science from USC and a bachelor of science in biological science from Cal Poly, Pomona. She holds a graduate certificate in effective supervision from Cal Poly Pomona and is a member of the Orange County Regulatory Association, DIA, PDA, AGRE and RAPS.

Von der hinteren Coverseite

An Overview of FDA Regulated Products: From Drugs and Cosmetics to Food and Tobacco, Second Edition is a complete reference and learning resource for those working in the regulatory affairs or aspiring to join the industry.

This book is fully updated to reflect recent advances in science and technology as well as new laws and regulations that have been implemented in recent years. Breakthroughs in cellular and gene therapy, immunotherapy, precision medicine, and digital health are constantly changing the face of healthcare and how these products are regulated. The updates brought about by the enactment of the 21st Century Cures Act and subsequent PDUFA Reauthorizations, as well as the signing into law the “Modernization of Cosmetic Regulation Act of 2022,” which will transform FDA’s oversight of cosmetics are fully reflected in all chapters of the book.

An Overview of FDA Regulated Products: From Drugs and Cosmetics to Food and Tobacco, Second Edition provides graduate students and industry professionals with the key understanding of approval processes with the FDA and other country regulation organizations. Regulatory science Professionals working with not only Drugs, but Biologics, Medical Devices, Food and Additives, Cosmetics, Veterinary products, and Tobacco will benefit from the comprehensive overview of the regulatory environment established to approve these products.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Verlag
Academic Press
Erscheinungsdatum
2025
Sprache
Englisch
ISBN 10 
0443237808
ISBN 13 
9780443237805
Einband
Taschenbuch
Auflage
2
Anzahl der Seiten
384
Herausgeber
Pacifici
Kontakt zum Hersteller
Elsevier Science & Technology
tradeorders@elsevier.com

London Wall 125
London
EC2Y 5AS
Vereinigtes Königreich
Verantwortliche Person
Elsevier B.V.
productsafety@elsevier.com

Radarweg 29
Amsterdam
1043 NX
Niederlande